| pubmed-article:8077715 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8077715 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:8077715 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:8077715 | lifeskim:mentions | umls-concept:C0038402 | lld:lifeskim |
| pubmed-article:8077715 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:8077715 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:8077715 | lifeskim:mentions | umls-concept:C0026249 | lld:lifeskim |
| pubmed-article:8077715 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:8077715 | lifeskim:mentions | umls-concept:C1280464 | lld:lifeskim |
| pubmed-article:8077715 | lifeskim:mentions | umls-concept:C1516240 | lld:lifeskim |
| pubmed-article:8077715 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8077715 | pubmed:dateCreated | 1994-10-6 | lld:pubmed |
| pubmed-article:8077715 | pubmed:abstractText | The proliferative response of lymphocytes induced by a new streptococcal mitogenic factor (MF) and the streptococcal pyrogenic exotoxins (Spe) A and B was determined in sera from 6 healthy persons. Responses were compared to those obtained from reference serum that lacked mitogen-specific ELISA antibodies. The sera showed individual variations in the levels of MF- and Spe-specific antibodies, as determined by ELISA. The experiments showed that most human sera, which contained mitogen-specific antibodies, could neutralize the mitogenicity of the proteins. However, there were sera that contained mitogen-specific antibodies but that did not inhibit the toxin-induced proliferation. Thus, the ELISA antibody titer did not always equal the neutralizing capacity. Sera from 27 patients with group A streptococcal bacteremia had significantly lower neutralizing ability against MF and SpeB than did sera from 25 uncomplicated tonsillitis cases. | lld:pubmed |
| pubmed-article:8077715 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8077715 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8077715 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8077715 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8077715 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8077715 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8077715 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8077715 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8077715 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8077715 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8077715 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8077715 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8077715 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:8077715 | pubmed:issn | 0022-1899 | lld:pubmed |
| pubmed-article:8077715 | pubmed:author | pubmed-author:HolmS ESE | lld:pubmed |
| pubmed-article:8077715 | pubmed:author | pubmed-author:NorgrenMM | lld:pubmed |
| pubmed-article:8077715 | pubmed:author | pubmed-author:PauksensKK | lld:pubmed |
| pubmed-article:8077715 | pubmed:author | pubmed-author:Norrby-Teglun... | lld:pubmed |
| pubmed-article:8077715 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8077715 | pubmed:volume | 170 | lld:pubmed |
| pubmed-article:8077715 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8077715 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8077715 | pubmed:pagination | 585-91 | lld:pubmed |
| pubmed-article:8077715 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:meshHeading | pubmed-meshheading:8077715-... | lld:pubmed |
| pubmed-article:8077715 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8077715 | pubmed:articleTitle | Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. | lld:pubmed |
| pubmed-article:8077715 | pubmed:affiliation | Department of Clinical Bacteriology, University of Umeå, Sweden. | lld:pubmed |
| pubmed-article:8077715 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8077715 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8077715 | lld:pubmed |
